Enterome
By submitting your information in this e-mail message, you agree that such information will be governed by our Privacy Policy related to personal data.
Enterome Press Releases - Enterome Press Releases All 2026 2025 2024 2023 2022 2021 2020 15 June 2026 Enterome presents Phase 1/2 iNHL interim data at EHA demonstrating durable OncoMimics™-induced CD8 T cell responses and clinical activity Read more 28 May 2026 Enterome receives U.S. FDA Orphan Drug Designation for EO2463 OncoMimics™ to treat “watch-and-wait” indolent non-Hodgkin lymphoma Read more 12 May 2026 Enterome presents Phase 2 indolent non-Hodgkin lymphoma data at EHA showing EO2463 induces B cell target-specific CD8 T-cell expansion correlating with clinical outcomes Read more 29 Jan
saved by
related reading
- Gap Mapgap-map.org
- Publications - O'Sullivan labosullivanlab.com
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- Immune Regulation | People | Osaka University Immunology Frontier Research Centerifrec.osaka-u.ac.jp
- Diet and microbiome in the beginning of the sequence of gut inflammation - PMCncbi.nlm.nih.gov
- Thymosin alpha 1: A comprehensive review of the literaturencbi.nlm.nih.gov
- Faecal transplants can treat some cancers — but probably won’t ever be widely usednature.com
- Mesa — JURA Bio, Inc.jura.bio
- Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancernature.com
- Medicine's Endgamenotboring.co
- Google’s Gemma AI model helps discover new potential cancer therapy pathwayblog.google
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov